IOVA
Iovance Biotherapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$3.96
-0.11 ▼ -2.70%
🌙 3월 13일 7:59 PM ET (한국 3/14 08:59)
$3.96
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -1.12 | Insider Own | 14.7% | Shs Outstand | 0.41B | Perf Week | -22.81% |
| Market Cap | 1.63B | Forward P/E | - | EPS next Y | 55.72% | Insider Trans | - | Shs Float | 0.35B | Perf Month | 52.31% |
| Enterprise Value | 1.38B | PEG | - | EPS next Q | -0.14 | Inst Own | 57.15% | Short Float | 37.26% | Perf Quarter | 75.22% |
| Income | -0.39B | P/S | 6.19 | EPS this Y | 54% | Inst Trans | 15.14% | Short Ratio | 8.53 | Perf Half Y | 63.64% |
| Sales | 0.26B | P/B | 2.34 | EPS next 5Y | - | ROA | -42.88% | Short Interest | 130.93M | Perf YTD | 45.05% |
| Book/sh | 1.7 | P/C | 5.49 | EPS past 3/5Y | 23.93% 10.23% | ROE | -55.5% | 52W High | -29.66% ($5.63) | Perf Year | 12.5% |
| Cash/sh | 0.72 | P/FCF | - | Sales past 3/5Y | - | ROIC | -52.62% | 52W Low | 141.68% ($1.64) | Perf 3Y | -39.08% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 13.67% | Gross Margin | 17.09% | Volatility(W/M) | 11.95% 10.57% | Perf 5Y | -88.58% |
| Dividend TTM | - | EV/Sales | 5.25 | Sales Y/Y TTM | 60.57% | Oper. Margin | -151.18% | ATR (14) | 0.42 | Perf 10Y | -21.58% |
| Dividend Ex-Date | - | Quick Ratio | 2.83 | EPS Q/Q | 31.43% | Profit Margin | -148.41% | RSI (14) | 53.18 | Recom | 1.64 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.2 | Sales Q/Q | 17.66% | SMA20 | 3.17% ($3.84) | Beta | 0.71 | Target Price | $9 |
| Payout | - | Debt/Eq | 0.07 | Earnings | 2000000 | SMA50 | 28.96% ($3.07) | Rel Volume | 1.26 | Prev Close | $4.07 |
| Employees | 975 | LT Debt/Eq | 0.06 | EPS/Sales Surpr. | -2.92% 7.44% | SMA200 | 60.09% ($2.47) | Avg Volume(3M) | 15.35M | Price | $3.96 |
| IPO | 2009/9/1 | Option/Short | Yes/Yes | Trades | 36985 | Volume | 19,365,566 | Change | -2.7% |
뉴스 로딩 중...